8.01MXN
12.13 BMXN
111.36 BMXN
1.22 B
About TERUMO CORP
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Employees (FY)
30.21 K
Founded
1921
ISIN
JP3546800008
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4543/N is 274.75 MXN — it has decreased by 16.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange TERUMO CORP stocks are traded under the ticker 4543/N.
TERUMO CORP is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4543/N stock is 19.82% volatile and has beta coefficient of 1.07. Check out the list of the most volatile stocks — is TERUMO CORP there?
4543/N earnings for the last quarter are 2.16 MXN per share, whereas the estimation was 1.85 MXN resulting in a 16.88% surprise. The estimated earnings for the next quarter are 2.38 MXN per share. See more details about TERUMO CORP earnings.
TERUMO CORP revenue for the last quarter amounts to 26.67 B MXN despite the estimated figure of 25.56 B MXN. In the next quarter revenue is expected to reach 27.38 B MXN.
Yes, you can track TERUMO CORP financials in yearly and quarterly reports right on TradingView.
4543/N stock has fallen by 16.54% compared to the previous week, the month change is a 16.54% fall, over the last year TERUMO CORP has showed a 12.30% increase.
4543/N net income for the last quarter is 3.59 B MXN, while the quarter before that showed 3.21 B MXN of net income which accounts for 11.67% change. Track more TERUMO CORP financial stats to get the full picture.
Today TERUMO CORP has the market capitalization of 426.73 B, it has decreased by 5.23% over the last week.
TERUMO CORP dividend yield was 1.12% in 2022, and payout ratio reached 33.61%. The year before the numbers were 0.91% and 28.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4543/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERUMO CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 30.21 K employees. See our rating of the largest employees — is TERUMO CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TERUMO CORP technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TERUMO CORP stock shows the sell signal. See more of TERUMO CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TERUMO CORP future price: according to them, 4543/N price has a max estimate of 392.94 MXN and a min estimate of 271.18 MXN. Read a more detailed TERUMO CORP forecast: see what analysts think of TERUMO CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TERUMO CORP EBITDA is 24.17 B MXN, and current EBITDA margin is 22.87%. See more stats in TERUMO CORP financial statements.